Martin Shkreli, also known as “Pharma Bro,” recently shared his short positions on Bitcoin, MicroStrategy, and several quantum computing stocks. He argued that these assets were overvalued and predicted a significant correction. However, his track record and controversial persona have raised questions about his credibility.
Despite this, it’s important to note that contrarian investment strategies can be profitable if executed correctly.
Source
